
107 Neratinib-Based Combination Treatments for Patients With HER2-Positive Breast Cancer Brain Metastases
Background Breast cancer brain metastases (BCBM) contribute to substantial morbidity and mortality in patients with HER2-positive (HER2+) metastatic breast cancer. The central nervous system (CNS) is a common site of recurrence in patients with HER2+ …